By Sue Iannone Imagine this: You are a training manager in the L&D Department of a biotech company, supporting the leading brand. The sales leader of the team comes to you and states, “Our sales reps are struggling with closing the call with their customers. We need to teach these reps how to close. Can […]
By Sue Iannone In life sciences, business reviews are conducted frequently in the commercial areas, especially sales, marketing, and market access. During these business reviews, leaders from different areas provide updates on what they’ve been doing, how well they’ve been doing it, and what’s next on the horizon. When does the Learning & Development (L&D) […]
By Nathan Pienkowski Should a Learning and Development (L&D) organization deliver above and beyond the call of duty, going “all in” to apply the latest in instructional design to every single project? That’s an interesting question and, like most interesting questions, it defies a simple yes or no answer. Sometimes, the answer is yes. However, […]
By Sue Iannone We all…well, maybe some of us…remember the chorus lyrics from a famous Rolling Stones song: You can’t always get what you want But if you try sometimes you just might find You get what you need It’s tough to argue with that. It holds true in everyday life, and it holds true […]
By Sue Iannone Let’s start this article by establishing one fact up front: That old cliché about how we all should “do more with less” is bogus. Perhaps not it all cases, but it’s definitely bogus when it comes to leading a Learning and Development (L&D) organization in a biopharma company. Training organization leaders often […]
By Sue Iannone Part Two in a Series In Part One, we outlined seven characteristics of the “Future Learning and Development Organization.” Those characteristics are shared by teams that evolve beyond firefighting mode, look forward in a strategic way, and focus on achieving the company’s business objectives rather than struggling to keep up with daily […]
By Sue Iannone and Garry O’Grady Part One in a Series The biopharmaceutical industry is not known for dull stability. Think about it… Companies must remain on a “treadmill” of innovation, always working to replace products as they go off patent. Regulatory and legislative changes are always being discussed, passed, or implemented. Market dynamics are […]
